Deck Kelly 4
4 · Inhibrx, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-03-13$35.43/sh−32,431$1,148,998→ 2,087 totalExercise: $11.25Exp: 2030-04-21→ Common Stock (32,431 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on April 21, 2021, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
- [F2]The stock options were exercised in multiple transactions at prices ranging from $35.40 to $35.50, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.